Efficacy of a Multiplex Paclitaxel Emission Stent Using a Pluronic® Mixture Membrane versus a Covered Metal Stent in Malignant Biliary Obstruction: A Prospective Randomized Comparative Study

Background/Aims A drug-eluting stent for unresectable malignant biliary obstruction was developed to increase stent patency by preventing tumor ingrowth. The safety and efficacy of a new generation of metallic stents covered with a paclitaxel-incorporated membrane using a Pluronic® mixture (MSCPM-II) were compared prospectively with those of covered metal stents (CMSs) in patients with malignant biliary obstructions. Methods This study was initially designed as a prospective randomized trial but was closed early because of a high incidence of early occlusion. Therefore, the data were analyzed using the intent-to-treat method. A total of 72 patients with unresectable distal malignant biliary obstructions were prospectively enrolled. Results The two groups did not differ significantly in basic characteristics and mean follow-up period (MSCPM-II 194 days vs CMS 277 days, p=0.063). Stent occlusion occurred in 14 patients (35%) who received MSCPM-II and in seven patients (21.9%) who received CMSs. Stent patency and survival time did not significantly differ between the two groups (p=0.355 and p=0.570). The complications were mild and resolved by conservative management in both groups. Conclusions There were no significant differences in stent patency or patient survival in MSCPM-II and CMS patients with malignant biliary obstructions.

[1]  Ki Seong Lee,et al.  Partially covered versus uncovered self-expandable nitinol stents with anti-migration properties for the palliation of malignant distal biliary obstruction: A randomized controlled trial , 2015, Scandinavian journal of gastroenterology.

[2]  Dong Ki Lee,et al.  Nonvascular drug-eluting stent coated with sodium caprate-incorporated polyurethane for the efficient penetration of paclitaxel into tumor tissue , 2015, Journal of biomaterials applications.

[3]  T. Itoi,et al.  TOKYO criteria 2014 for transpapillary biliary stenting , 2015, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[4]  G. Costamagna,et al.  Prospective evaluation of the partially covered nitinol "ComVi" stent for malignant non hilar biliary obstruction. , 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[5]  P. Stotzer,et al.  Covered and uncovered self-expandable metallic Hanarostents are equally efficacious in the drainage of extrahepatic malignant strictures. Results of a double-blind randomized study , 2013, Scandinavian journal of gastroenterology.

[6]  Jie Hyun Kim,et al.  Efficacy of a Metallic Stent Covered with a Paclitaxel-Incorporated Membrane Versus a Covered Metal Stent for Malignant Biliary Obstruction: A Prospective Comparative Study , 2013, Digestive Diseases and Sciences.

[7]  H. Körner,et al.  Long-term outcome of palliative treatment with self-expanding metal stents for malignant obstructions of the GI tract , 2012, Scandinavian journal of gastroenterology.

[8]  Jie Hyun Kim,et al.  Porcine feasibility and safety study of a new paclitaxel-eluting biliary stent with a Pluronic-containing membrane , 2012, Endoscopy.

[9]  M. Chung,et al.  Safety evaluation of self‐expanding metallic biliary stents eluting gemcitabine in a porcine model , 2012, Journal of gastroenterology and hepatology.

[10]  N. Sasahira,et al.  Covered metallic stenting for malignant distal biliary obstruction: clinical results according to stent type , 2011, Journal of hepato-biliary-pancreatic sciences.

[11]  S. Yun,et al.  Paclitaxel-eluting covered metal stents versus covered metal stents for distal malignant biliary obstruction: a prospective comparative pilot study. , 2010, Gastrointestinal endoscopy.

[12]  Dong Ki Lee,et al.  Drug-eluting stent in malignant biliary obstruction. , 2009, Journal of hepato-biliary-pancreatic surgery.

[13]  Ho-Young Song,et al.  Histologic influence of paclitaxel-eluting covered metallic stents in a canine biliary model. , 2009, Gastrointestinal endoscopy.

[14]  N. Sasahira,et al.  Management of distal malignant biliary obstruction with the ComVi stent, a new covered metallic stent , 2009, Surgical Endoscopy.

[15]  Sung-Bae Kim,et al.  Membrane degradation of covered stents in the upper gastrointestinal tract: frequency and clinical significance. , 2008, Journal of vascular and interventional radiology : JVIR.

[16]  N. Sasahira,et al.  Efficacy and Safety of Metallic Stents in Patients With Unresectable Pancreatic Cancer Receiving Gemcitabine , 2007, Pancreas.

[17]  Dong Ki Lee,et al.  Human application of a metallic stent covered with a paclitaxel-incorporated membrane for malignant biliary obstruction: multicenter pilot study. , 2007, Gastrointestinal endoscopy.

[18]  R. Cameron,et al.  Analysis and evaluation of a biomedical polycarbonate urethane tested in an in vitro study and an ovine arthroplasty model. Part II: in vivo investigation. , 2005, Biomaterials.

[19]  Dong Ki Lee,et al.  The effect on porcine bile duct of a metallic stent covered with a paclitaxel-incorporated membrane. , 2005, Gastrointestinal endoscopy.

[20]  E. Edelman,et al.  Impact of transport and drug properties on the local pharmacology of drug-eluting stents , 2003, International journal of cardiovascular interventions.

[21]  A. Kabanov,et al.  Design and formulation of polyplexes based on pluronic-polyethyleneimine conjugates for gene transfer. , 2002, Bioconjugate chemistry.

[22]  Dong Ki Lee,et al.  Features of malignant biliary obstruction affecting the patency of metallic stents: a multicenter study. , 2002, Gastrointestinal endoscopy.

[23]  K. Hausegger,et al.  Treatment of malignant biliary obstruction with polyurethane-covered Wallstents. , 1998, AJR. American journal of roentgenology.

[24]  P. Craig,et al.  A three year follow up of self expanding metal stents in the endoscopic palliation of longterm survivors with malignant biliary obstruction. , 1995, Gut.

[25]  P. Cotton,et al.  Randomised trial of endoscopic steriting versus surgical bypass in malignant low bileduct obstruction , 1994, The Lancet.

[26]  J. Pausch,et al.  A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. , 1993, Endoscopy.

[27]  K. Klose,et al.  Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction. A prospective and randomized trial. , 1993, Endoscopy.

[28]  K. Hausegger,et al.  Malignant biliary obstruction: histologic findings after treatment with self-expandable stents. , 1992, Radiology.

[29]  A. Kruse,et al.  Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. , 1989, Gut.